Portfolio company
Moleculo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Moleculo develops DNA library preparation and analysis technology for researchers to assemble short sequences into accurate, synthetic long reads.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Molecular Assemblies
This company develops enzymatic DNA synthesis technology to provide long, high-quality oligonucleotides for researchers in synthetic biology, therapeutics, diagnostics and data storage.
Moleculent
Moleculent develops a functional profiling platform and automated instruments for mapping cell-to-cell communication in human tissue to support pharmaceutical and academic researchers.
Population Genetics
This company develops molecular and sample barcoding technology to enable cost-effective next-generation sequencing of large DNA populations for clinical and research laboratories.
Geneseque
This company develops a single-molecule DNA sequencing technology for the life sciences sector and research partners.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Singular Bio
The company develops single molecule detection technology for cell-free DNA analysis to provide non-invasive prenatal screening for the healthcare and genomics sectors.
ArgenTAG
This company develops single-cell genomic sequencing kits and barcoding technology for researchers to analyse complex biological data using long-read sequencing platforms.
Seed, 2024
This company develops a single-molecule DNA sequencing platform for clinical diagnostics, agriculture, and biosecurity sectors.